Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
• NP403778.RAgkZ19c9cJCHRxCVTt4w8LUA-yEs4z9iJJMZqdWLZI8o130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403778.RAgkZ19c9cJCHRxCVTt4w8LUA-yEs4z9iJJMZqdWLZI8o130_provenance.
• NP542981.RApb5b0e7t70jGnj7CIiQ3vOdc8tBoC2lNLGWR4_RhdLA130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542981.RApb5b0e7t70jGnj7CIiQ3vOdc8tBoC2lNLGWR4_RhdLA130_provenance.
• NP651053.RAh6U6H5-llgA1ADNPPzxcqOHFXmuuNqww9OUtDpon1ko130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651053.RAh6U6H5-llgA1ADNPPzxcqOHFXmuuNqww9OUtDpon1ko130_provenance.
• NP464773.RAiitvv3WOE3ObvUlqOLXYigSnqnjZpAJBFOBs60ABzFc130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP464773.RAiitvv3WOE3ObvUlqOLXYigSnqnjZpAJBFOBs60ABzFc130_provenance.
• NP589296.RAYR7XgpFcsu4CZZREg-jB8JFMN7qVVU58sUKGk-QVqf0130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589296.RAYR7XgpFcsu4CZZREg-jB8JFMN7qVVU58sUKGk-QVqf0130_provenance.
• NP783450.RAfpOlAxZTLwdbxTw8dvT1Mr5sbJKjVVBa9bGAs1m8q_Y130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783450.RAfpOlAxZTLwdbxTw8dvT1Mr5sbJKjVVBa9bGAs1m8q_Y130_provenance.
• NP366653.RAJV70Yve7fKg2H-W1z06kJWrRawZH57jA5kg1Hh6ZDuU130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366653.RAJV70Yve7fKg2H-W1z06kJWrRawZH57jA5kg1Hh6ZDuU130_provenance.
• NP581581.RAZXQtTJkiMTls3E099NwjuY9i5mwbotUR53Oq3Q4jVr8130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581581.RAZXQtTJkiMTls3E099NwjuY9i5mwbotUR53Oq3Q4jVr8130_provenance.
• NP396802.RAH7bByvR60GFFyQcKmxN2qdrbQb43bre8NVE9U0FXj0M130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396802.RAH7bByvR60GFFyQcKmxN2qdrbQb43bre8NVE9U0FXj0M130_provenance.
• NP660629.RAwUB4qR5J-kSI_5TCvcO3XFCoMdysz_s3GYMVqfWoSq4130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660629.RAwUB4qR5J-kSI_5TCvcO3XFCoMdysz_s3GYMVqfWoSq4130_provenance.
• NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571608.RAIf_MRsHnLU9v0RcGWvM9rJtXRze0-oDWXn6_IyNxYC8130_provenance.